$VRMMQ
Vroom, Inc.

2021 Q1 Form 10-K Financial Statement

#000156459021010584 Filed on March 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2019 Q4 2019
Revenue $591.1M $1.192B
YoY Change 57.31% 39.33%
Cost Of Revenue $554.9M $1.134B
YoY Change 55.28% 42.7%
Gross Profit $36.18M $57.86M
YoY Change 96.75% -4.85%
Gross Profit Margin 6.12% 4.85%
Selling, General & Admin $109.1M $185.0M
YoY Change 86.9% 38.21%
% of Gross Profit 301.62% 319.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.906M $3.010M $6.157M
YoY Change 199.59% -11.18%
% of Gross Profit 8.03% 10.64%
Operating Expenses $109.1M $185.0M
YoY Change 86.9% 38.21%
Operating Profit -$75.53M -$133.1M
YoY Change 84.41% 66.66%
Interest Expense $3.812M $14.60M
YoY Change 34.89% 71.46%
% of Operating Profit
Other Income/Expense, Net $15.00K $96.00K
YoY Change -54.55% -80.61%
Pretax Income -$77.03M -$142.8M
YoY Change 87.86% 68.11%
Income Tax $156.0K $168.0K
% Of Pretax Income
Net Earnings -$77.19M -$143.0M
YoY Change 88.0% 67.86%
Net Earnings / Revenue -13.06% -12.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$569.7K -$1.241M
COMMON SHARES
Basic Shares Outstanding 135.6M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $940.3M $217.7M
YoY Change 453.77% 34.63%
Cash & Equivalents $966.8M $217.7M $217.7M
Short-Term Investments
Other Short-Term Assets $51.30M $11.00M
YoY Change 14.51% 54.93%
Inventory $337.7M $205.7M $205.7M
Prepaid Expenses
Receivables $93.20M $30.85M $30.80M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.423B $465.3M $465.3M
YoY Change 231.35% 56.4%
LONG-TERM ASSETS
Property, Plant & Equipment $35.50M $7.828M $7.800M
YoY Change 38.67% 1.3%
Goodwill $159.3M $78.17M
YoY Change 103.79%
Intangibles $572.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $16.50M $12.06M $11.50M
YoY Change 21.32% 105.36%
Total Long-Term Assets $244.2M $98.06M $98.10M
YoY Change 107.3% 2.94%
TOTAL ASSETS
Total Short-Term Assets $1.423B $465.3M $465.3M
Total Long-Term Assets $244.2M $98.06M $98.10M
Total Assets $1.667B $563.4M $563.4M
YoY Change 204.64% 43.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $42.80M $18.99M $19.00M
YoY Change 167.5% 28.38%
Accrued Expenses $30.40M $38.49M $14.50M
YoY Change 112.59% 62.92%
Deferred Revenue $17.32M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $253.0M $173.6M
YoY Change 53.06% 67.08%
Total Short-Term Liabilities $455.1M $259.8M $259.8M
YoY Change 84.25% 70.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $200.0K
YoY Change -100.0% -98.75%
Other Long-Term Liabilities $16.00M $3.073M $2.900M
YoY Change 6.67% 26.09%
Total Long-Term Liabilities $16.00M $3.073M $3.100M
YoY Change 5.96% -83.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $455.1M $259.8M $259.8M
Total Long-Term Liabilities $16.00M $3.073M $3.100M
Total Liabilities $471.1M $262.9M $262.9M
YoY Change 79.67% 54.1%
SHAREHOLDERS EQUITY
Retained Earnings -$573.9M
YoY Change
Common Stock $8.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.196B -$573.9M $300.5M
YoY Change
Total Liabilities & Shareholders Equity $1.667B $563.4M $563.4M
YoY Change 204.64% 43.43%

Cashflow Statement

Concept 2021 Q1 2019 Q4 2019
OPERATING ACTIVITIES
Net Income -$77.19M -$143.0M
YoY Change 88.0% 67.86%
Depreciation, Depletion And Amortization $2.906M $3.010M $6.157M
YoY Change 199.59% -11.18%
Cash From Operating Activities $29.55M -$87.74M -$215.6M
YoY Change -217.53% 232.21%
INVESTING ACTIVITIES
Capital Expenditures $3.239M -$2.740M $3.528M
YoY Change 90.64% 71.1%
Acquisitions $76.15M
YoY Change
Other Investing Activities -$76.15M $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$79.38M -$2.740M -$3.528M
YoY Change 4572.4% -127.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.824M
YoY Change
Debt Paid & Issued, Net $25.00M
YoY Change 354.05%
Cash From Financing Activities -73.37M 207.5M 275.2M
YoY Change -864.29% 107.93%
NET CHANGE
Cash From Operating Activities 29.55M -87.74M -215.6M
Cash From Investing Activities -79.38M -2.740M -3.528M
Cash From Financing Activities -73.37M 207.5M 275.2M
Net Change In Cash -123.2M 117.1M 56.08M
YoY Change 614.46% -30.12%
FREE CASH FLOW
Cash From Operating Activities $29.55M -$87.74M -$215.6M
Capital Expenditures $3.239M -$2.740M $3.528M
Free Cash Flow $26.32M -$85.00M -$219.2M
YoY Change -198.03% 227.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
769000
CY2018 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
174000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84949000
CY2020 dei Trading Symbol
TradingSymbol
VRM
CY2020 dei Entity Registrant Name
EntityRegistrantName
VROOM, INC.
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Type
DocumentType
10-K
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
83257000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
114000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
96000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357700000
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001580864
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1191821000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1286155000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1133962000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
794622000
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
6300000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11572000
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity File Number
EntityFileNumber
001-39315
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1112566
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
1375 Broadway
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
Floor 11
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10018
CY2020 dei City Area Code
CityAreaCode
855
CY2020 dei Local Phone Number
LocalPhoneNumber
524-1300
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
135599684
CY2020Q2 dei Entity Public Float
EntityPublicFloat
4800000000
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1056213000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
217734000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
33826000
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1853000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60576000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
30848000
CY2020Q4 us-gaap Inventory Net
InventoryNet
423647000
CY2019Q4 us-gaap Inventory Net
InventoryNet
205746000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23617000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9149000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59405000
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
329231000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30275000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
259834000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12093000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2004841000
CY2020Q4 us-gaap Assets
Assets
1724056000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15776000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32925000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6052000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
482710000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24822000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3073000
CY2019Q4 us-gaap Liabilities
Liabilities
262907000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
132000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-573860000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-573852000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
789000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1597879000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
465330000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15092000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7828000
CY2020Q4 us-gaap Goodwill
Goodwill
78172000
CY2019Q4 us-gaap Goodwill
Goodwill
78172000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17137000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12057000
CY2019Q4 us-gaap Assets
Assets
563387000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18987000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38491000
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
173461000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
17323000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2151000
CY2020Q4 us-gaap Liabilities
Liabilities
496954000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
874332000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-777871000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1227102000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1724056000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
563387000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2803000
CY2020Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000
CY2019Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
86123364
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2019Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
83568628
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
83568628
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
113443854
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
134043969
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8650922
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
134043969
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8650922
CY2020 us-gaap Gross Profit
GrossProfit
71545000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
245546000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4598000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6019000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-178599000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-133148000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-79892000
CY2020 us-gaap Interest Expense
InterestExpense
9656000
CY2019 us-gaap Interest Expense
InterestExpense
14596000
CY2018 us-gaap Interest Expense
InterestExpense
8513000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
5896000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
5607000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
3135000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
20470000
CY2019 us-gaap Gross Profit
GrossProfit
57859000
CY2018 us-gaap Gross Profit
GrossProfit
60807000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
184988000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
133842000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6857000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2329000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32068000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2341000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6157000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3935000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2916000
CY2018 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
13036000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
495000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-202715000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-142810000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-202799000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
84000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
168000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
229000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-202799000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-142978000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-85178000
CY2019 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
132750000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-275728000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-98214000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.76
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-32.04
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-11.50
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73345569
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8605962
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8540778
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-201499000
CY2018 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201409Member
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1158000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000
CY2018 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
13036000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-296866000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2756000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
466000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1344000
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5824000
CY2019 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
132750000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2127000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
901046000
CY2020 vrm Stock Issued During Period Value Conversion Of Redeemable Convertible Preferred Stock Warrant To Common Stock Warrant
StockIssuedDuringPeriodValueConversionOfRedeemableConvertiblePreferredStockWarrantToCommonStockWarrant
21873000
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1818000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
3383000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13254000
CY2020 vrm Stock Issued During Period Value Withheld To Satisfy Employee Tax Withholding Obligations
StockIssuedDuringPeriodValueWithheldToSatisfyEmployeeTaxWithholdingObligations
2915000
CY2020 us-gaap Profit Loss
ProfitLoss
-202799000
CY2019 us-gaap Profit Loss
ProfitLoss
-142978000
CY2018 us-gaap Profit Loss
ProfitLoss
-85178000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4654000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6932000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
938000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
357000
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
279000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1031000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
13254000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
2756000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1158000
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-46000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-789000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3198000
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
6588000
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
2682000
CY2018 us-gaap Inventory Write Down
InventoryWriteDown
-1069000
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-789000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18430000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4556000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
6791000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9049000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
224489000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
92877000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11902000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9117000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
28431000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10131000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6291000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3487000
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7499000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
10902000
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
860000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
504024000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14066000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4035000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6527000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3105000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
19500000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5673000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-355254000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2062000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
14850000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11329000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3528000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12788000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
25000000
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5506000
CY2019 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
685000
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1242736000
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
992179000
CY2018 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
648309000
CY2020 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1086966000
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
914200000
CY2018 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
656194000
CY2020 vrm Payment Of Vehicle Floor Plan Upfront Commitment Fees
PaymentOfVehicleFloorPlanUpfrontCommitmentFees
2906000
CY2020 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
21694000
CY2019 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
227502000
CY2018 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
145899000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1818000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5824000
CY2020 vrm Common Stock Shares Withheld To Satisfy Employee Tax Withholding Obligations
CommonStockSharesWithheldToSatisfyEmployeeTaxWithholdingObligations
2915000
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
723000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
569471000
CY2020 vrm Payments Of Costs Related To Follow On Public Offering
PaymentsOfCostsRelatedToFollowOnPublicOffering
1519000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2341000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1810000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31000
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-316000
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
183000
CY2018 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-164000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1237035000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
275242000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
132375000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
870452000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
56078000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
80252000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
219587000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
163509000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
8540000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
12607000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
7743000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
163000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
157000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
212000
CY2019 vrm Accretion Of Redeemable Convertible Preferred Stock
AccretionOfRedeemableConvertiblePreferredStock
132750000
CY2018 vrm Accretion Of Redeemable Convertible Preferred Stock
AccretionOfRedeemableConvertiblePreferredStock
13036000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1090039000
CY2019 vrm Equity Issuance Costs Included In Accrued Liabilities
EquityIssuanceCostsIncludedInAccruedLiabilities
5020000
CY2020 vrm Conversion Of Redeemable Convertible Preferred Stock Warrant To Common Stock Warrant
ConversionOfRedeemableConvertiblePreferredStockWarrantToCommonStockWarrant
21873000
CY2020 vrm Issuance Of Common Stock As Upfront Payment To Nonemployee
IssuanceOfCommonStockAsUpfrontPaymentToNonemployee
2127000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
97000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
200000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28426000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.78%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue, and expenses and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to income taxes, the realizability of inventory, stock-based compensation, contingencies, revenue-related reserves, fair value measurements, goodwill, and useful lives of property and equipment and intangible assets. The Company bases its estimates on historical experience, market conditions, and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.78%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning in the first quarter of 2020, the COVID-19 pandemic negatively impacted, and may continue to negatively impact, the macroeconomic environment in the United States and globally, as well as the Company&#8217;s business, financial condition and results of operations. Due to the evolving and uncertain nature of COVID-19, it is reasonably possible that it could materially impact the Company&#8217;s estimates, particularly those noted above that require consideration of forecasted financial information, in the near to medium term. The ultimate impact will depend on numerous evolving factors that the Company may not be able to accurately predict, including the duration and extent of the pandemic, the impact of federal, state, local and foreign governmental actions, consumer behavior in response to the pandemic and other economic and operational conditions the Company may face. </p>
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17348000
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Significant Customers </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:6.78%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s principal financial instruments subject to potential concentration of credit risk are cash and cash equivalents and accounts receivable, which are unsecured. The Company&#8217;s cash balances are maintained at various large financial institutions. Deposits held with financial institutions may at times exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and, therefore, management believes they bear minimal risk. The Company&#8217;s cash equivalents primarily consist of money market funds that hold investments in highly liquid US treasury securities. Concentration of credit risk with respect to accounts receivable is generally mitigated by a large customer base. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.78%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the years ended December 31, 2020, 2019, and 2018, no customer represented 10% or more of the Company&#8217;s revenues and no customer represented more than 10% of the Company&#8217;s accounts receivable as of December 31, 2020 and 2019. </p>
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13334000
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2020Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10800000
CY2020 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2020Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
2-for-1
CY2020Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
54.50
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
569500000
CY2020Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1500000
CY2020 us-gaap Number Of Reporting Units
NumberOfReportingUnits
3
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
18400000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17400000
CY2019Q4 vrm Reserve For Chargebacks
ReserveForChargebacks
3300000
CY2020Q4 vrm Reserve For Chargebacks
ReserveForChargebacks
3800000
CY2019Q4 vrm Cumulative Profit Sharing Payment Recognized
CumulativeProfitSharingPaymentRecognized
6900000
CY2020Q4 vrm Cumulative Profit Sharing Payment Recognized
CumulativeProfitSharingPaymentRecognized
11500000
CY2020 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2020Q4 vrm Vehicles
Vehicles
421458000
CY2019Q4 vrm Vehicles
Vehicles
203290000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4909000
CY2020Q4 vrm Parts And Accessories
PartsAndAccessories
2189000
CY2019Q4 vrm Parts And Accessories
PartsAndAccessories
2456000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
12900000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3204000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3026000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9520000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2746000
CY2020Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2019Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
9106000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3158000
CY2020Q4 vrm Accrued Vehicle Related Expenses Current
AccruedVehicleRelatedExpensesCurrent
13062000
CY2019Q4 vrm Accrued Vehicle Related Expenses Current
AccruedVehicleRelatedExpensesCurrent
8923000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
15443000
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
7455000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5749000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3386000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4890000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2964000
CY2019Q4 vrm Accrued Series H Preferred Stock Issuance Costs Current
AccruedSeriesHPreferredStockIssuanceCostsCurrent
5020000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11155000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7585000
CY2020Q4 vrm Vehicle Payable Current
VehiclePayableCurrent
25086000
CY2019Q4 vrm Vehicle Payable Current
VehiclePayableCurrent
8904000
CY2020Q4 vrm Other Current
OtherCurrent
5189000
CY2019Q4 vrm Other Current
OtherCurrent
2668000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2020Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.034
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
5503000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
350000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
1915000
CY2020 us-gaap Sublease Income
SubleaseIncome
445000
CY2020 us-gaap Lease Cost
LeaseCost
7323000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
5524000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4600000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6577000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5318000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3398000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3111000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
907000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
19311000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1166000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
18145000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
5509000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
699000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
20093000
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
7200000
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
5700000
CY2019Q4 vrm Number Of Outstanding Series Of Redeemable Convertible Preferred Stock
NumberOfOutstandingSeriesOfRedeemableConvertiblePreferredStock
8
CY2019 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
132800000
CY2020Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
85533394
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
694447000
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2235442
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.01
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.06
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
3.86
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
11.86
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.46
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
15400000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2073006
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On June 11, 2020, the Company amended its certificate of incorporation to effect a 2-for-1 forward stock split of shares of the Company’s outstanding common stock, such that each share of common stock, $0.001 par value became two shares of common stock, $0.001 par value per share.
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
237334
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
8230
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6340000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
420500
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
598406
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
544526
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5617568
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2684160
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3449606
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.92
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.46
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.91
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.48
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.35
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.58
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.83
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M19D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M29D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y4M28D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y8M26D
CY2020 vrm Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value Of Common Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueOfCommonStock
10.46
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.363
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.366
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.97
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
22400000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
205700000
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
128100000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
408000
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1300000
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
0
CY2020Q4 vrm Segment Assets
SegmentAssets
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
84000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
168000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
229000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
84000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
168000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
229000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7853010
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0004
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0012
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0027
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-42570000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-29990000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-17839000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-5417000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1096000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
180000
CY2020 vrm Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
1264000
CY2019 vrm Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
772000
CY2018 vrm Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
229000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
46901000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
30051000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
17756000
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-94000
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
431000
CY2018 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-97000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
121859000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
74959000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
44900000
CY2018Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
27500000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
102252000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
66879000
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
12409000
CY2019Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
5911000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
3119000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
840000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1456000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
867000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
114000
CY2020Q4 vrm Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
4175000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
1809000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
173000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
836000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
423000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
126056000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
75207000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4197000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
248000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
225000
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
248000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
29000
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
3943000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
4197000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
248000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
93497146
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
73920658

Files In Submission

Name View Source Status
0001564590-21-010584-index-headers.html Edgar Link pending
0001564590-21-010584-index.html Edgar Link pending
0001564590-21-010584.txt Edgar Link pending
0001564590-21-010584-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gxcvnuuzgwwv000001.jpg Edgar Link pending
gxcvnuuzgwwv000002.jpg Edgar Link pending
gxcvnuuzgwwv000003.jpg Edgar Link pending
gxcvnuuzgwwv000004.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrm-10k_20201231.htm Edgar Link pending
vrm-20201231.xml Edgar Link completed
vrm-20201231.xsd Edgar Link pending
vrm-20201231_cal.xml Edgar Link unprocessable
vrm-20201231_def.xml Edgar Link unprocessable
vrm-20201231_lab.xml Edgar Link unprocessable
vrm-20201231_pre.xml Edgar Link unprocessable
vrm-ex1011_1117.htm Edgar Link pending
vrm-ex1014_1407.htm Edgar Link pending
vrm-ex1015_995.htm Edgar Link pending
vrm-ex1017_812.htm Edgar Link pending
vrm-ex1018_813.htm Edgar Link pending
vrm-ex1019_994.htm Edgar Link pending
vrm-ex1025_1623.htm Edgar Link pending
vrm-ex104_993.htm Edgar Link pending
vrm-ex105_992.htm Edgar Link pending
vrm-ex211_962.htm Edgar Link pending
vrm-ex231_1035.htm Edgar Link pending
vrm-ex311_9.htm Edgar Link pending
vrm-ex312_7.htm Edgar Link pending
vrm-ex321_10.htm Edgar Link pending
vrm-ex322_8.htm Edgar Link pending
vrm-ex43_991.htm Edgar Link pending